Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

7,983 public trials 1,815 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

Using Urine Samples to Identify Lung Cancer

NCT06033248

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

NCT07472517

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +9 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Bioresearch Partner - Hialeah Hospital Hialeah, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 242 locations
View Trial Details
Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

NCT06996782

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 103 locations
View Trial Details
Recruiting

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

NCT05098132

Conditions
1st Line NSCLC, Advanced Solid Tumor, Bronchial Neoplasms, +11 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 47 locations
View Trial Details
Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

NCT06899126

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Orange Coast Memorial Medical Center Fountain Valley Fountain Valley, California, United States
  • California Research Institute Los Angeles, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
View all 237 locations
View Trial Details
Recruiting

A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

NCT07253142

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Fujian Cancer Hospital Fu'zhou, Fujian, China
  • Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The People's Hospital of Guangxi Zhuangzu Autonomous Region Nanning, Guangxi, China
View Trial Details
Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

NCT06765109

Conditions
Anaplastic Lymphoma Kinase-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 157 locations
View Trial Details
Recruiting

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

NCT07459634

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Valkyrie Clinical Trials, Inc. Los Angeles, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Carolina Blood and Cancer Care Rock Hill, South Carolina, United States
View Trial Details

Related conditions